A selective inhibitor of oncogenic JNK signalling perturbs metastatic outgrowth of triple-negative breast cancer through metabolic blockade
Sharissa L. Latham, Yolande E. I. O’Donnell, Oscar Girgis-Cook, Misaki S. Clearwater, Nicole S. Bryce, Ellie T. Y. Mok, Sophie A Lynn, Jing Ni, Stephanie Alfred, King Ho Leong, Lake‐Ee Quek, Kendelle Joan Murphy, Chiara Pantarelli, Iliya Dragutinovic, Marjan Mojtabavi Naeini, , David R. Croucher
The paper identifies a selective JNK inhibitor that blocks metastasis in triple-negative breast cancer by targeting metabolic pathways.
bioRxiv · Apr 16, 2025 · PreprintCancer Biology